Across the board, the United States boasts a higher five-year relative survival rate than the European average, according to a
2008 study in the British medical journal
Lancet. For breast cancer, for instance, the U.S. survival rate was 83.9 percent, the U.K. rate was 69.7, and the average European rate was 73.1.
The American Cancer Society
found that the five-year
survival rates for colorectal cancer averaged 63 percent for the privately insured but
49 percent for the uninsured. According to the
Lancet study, five-year relative survival rates for colorectal cancer were 59.1 percent in the U.S. and
45.3 percent in Europe.
Breast cancer survival rates among the uninsured were also similar to Europe – 85 percent survival for those with private insurance, 75 percent for the uninsured, close to the European average. Rates for people on Medicaid were similar to the uninsured.